REGULATORY

FRI, JULY 16, 2021 09:00 CET

RLS GLOBAL AB (publ) INTERIM REPORT, Q2, 2021

APRIL 1st – JUNE 30th
  • Net sales amounted to TSEK 244 (TSEK 739)
  • Earnings before interest and taxes (EBIT) amounted to MSEK 8,5 (MSEK -5,6)
  • Other income TSEK 15 429 (TSEK 281)
  • Earning per share before dilution at SEK SEK 0,13 (SEK-0,09)
  • Cash flow from operating activities amounted to MSEK -6,280 (MSEK-5 472)
  • Liquid assets at the end of the period MSEK 6,9 (MSEK 30,3)
  • Equity ratio was 87% (91%)
JAN 1st _ JUNE 30th
  • Net sales amounted to TSEK 302 (TSEK 1 112)
  • Earnings before interest and taxes (EBIT) amounted to MSEK 2,2 (MSEK-9,5)
  • Other income TSEK 15 429 (TSEK 281)
  • Earning per share before dilution at SEK 0,03 (SEK -0,14)
  • Cash flow from operating activities amounted to MSEK -12,1 (MSEK -10,9)
  • Liquid assets at the end of the period MSEK 6,9 (MSEK 30,3)
  • Equity ratio was 87% (91%)
SUMMARY OF EVENTS DURING SECOND QUARTER
  • RLS arranged AGM on June 17.
  • RLS signed a global distribution agreement with ConvaTec.
  • ChloraSolv is regulatory approved for sale in Kuwait.
  • ChloraSolv01 is published in Journal of Wound Care.
COVID-19
  • In the current situation, the Board has considered the impact of different possible future covid-19 related scenarios in order to be prepared for future outcomes.
TRADING PLACE AND CERTIFIED ADVISER

RLS Global’s shares have been listed on the Nasdaq First North Growth Market since 17th May, 2017 and trading takes place under the short name RLS. Certified Adviser is Redeye Aktiebolag, phone: +46 8 121 576 90, email: certifiedadviser@redeye.se. During the period 2012 – 2017, the company was listed on Aktietorget.

CONTACT INFORMATION

Karin Fischer, CEO
E-mail: karin.fischer@rlsglobal.se
Telephone: +46 702 48 46 51

Eva Jagenheim, CFO
E-mail: eva.jagenheim@rlsglobal.se
Telephone: +46 730 23 13 57

PUBLICATION

This information was submitted for publication through the agency of the above contact person, at 09.00 CET on July 16th, 2021.

RLS GLOBAL AB (publ) INTERIM REPORT, Q2, 2021